Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rabo Securities is the investment banking arm of Rabobank, a leading global financial services provider headquartered in the Netherlands. The firm offers a comprehensive suite of financial services, including mergers and acquisitions (M&A) advisory, equity capital markets, and debt financing. While not a biotechnology or pharmaceutical developer itself, Rabo Securities maintains a specialized Healthcare and Life Sciences team that provides strategic financial advice to companies within these sectors. The company supports a diverse client base ranging from emerging biotech firms to large-scale pharmaceutical corporations and healthcare providers. By leveraging Rabobank's extensive global network and deep industry knowledge, Rabo Securities facilitates capital raising and strategic partnerships essential for innovation in the life sciences. Their expertise covers various sub-sectors, including medical technology, digital health, and traditional drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rabo Securities.